Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Citius Pharmaceuticals, Inc.

NASDAQ: CTXRHealthcare / Biotechnology / -
1.05-0.0400-3.67%Vol 80 2881Y Perf -70.56%
Feb 21st, 2019 16:00
BID1.05 ASK1.07
Open1.08 Previous Close1.09
Pre-Market- After-Trading-
 - -%  - -%
Target Price
6.50 
Analyst Rating
Strong Buy 1.00
Potencial %
519.05 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)19 
Earnings Rating
Price Range Ratio 52wk %
6.60 
Earnings Date
-

Today's Price Range

1.021.08

 

52wk Range

0.86003.74

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Month
-6.25%
3 Months
-19.85%
6 Months
-23.36%
1 Year
-70.56%
3 Years
-97.20%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CTXR1.05-0.0400-3.67
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
3.10
Current Ratio
3.20
Long Term Debt to Total Capital
-
Total Debt to Equity
0.01
Interest Coverage
-790.60
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.58
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-1.80
Cash Flow Per Share
-1.05
Price to Tangible Book
2.35
Book Value per Share
1.57
Enterprise Value (in ths.)
7 186
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-69.28
ROE last 12 Months
-50.33
Return on Assets (5Y Avg)
-25.61
ROA last 12 Months
-45.20
Return on Capital (5Y Avg)
-
ROC last 12 Months
-49.92
Return on invested Capital Q
-11.41
Return on invested Capital Y
-11.41
Assets Turnover
0.00
Receivables Turnover
0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.21-5.00Negative
3/2019 QR-0.20-122.22Negative
9/2019 FY-0.56-14.29Negative
9/2020 FY0.06-96.61Negative
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume80 288
Shares Outstanding (in ths.)18 520
Trades Count75
Dollar Volume80 344
Avg. Volume196 392
Avg. Weekly Volume204 443
Avg. Monthly Volume138 526
Avg. Quarterly Volume133 247

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

49%51%

Bearish Bullish

57%43%

Bearish Bullish

49%51%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News